Ziad Massy

1.1k total citations
11 papers, 417 citations indexed

About

Ziad Massy is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Nutrition and Dietetics. According to data from OpenAlex, Ziad Massy has authored 11 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Nutrition and Dietetics. Recurrent topics in Ziad Massy's work include Dialysis and Renal Disease Management (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Parathyroid Disorders and Treatments (2 papers). Ziad Massy is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Parathyroid Disorders and Treatments (2 papers). Ziad Massy collaborates with scholars based in France, Belgium and Spain. Ziad Massy's co-authors include Gérard M. London, Carmine Zoccali, Alberto Ortíz, Gunnar H. Heine, Mehmet Kanbay, Patrick Rossignol, Francesca Mallamaci, Raymond Vanholder, Denis Fouque and Sophie Liabeuf and has published in prestigious journals such as The Lancet, Clinical Journal of the American Society of Nephrology and The Lancet Diabetes & Endocrinology.

In The Last Decade

Ziad Massy

8 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziad Massy France 5 181 137 107 91 56 11 417
Rossella Siligato Italy 12 169 0.9× 75 0.5× 91 0.9× 49 0.5× 49 0.9× 31 433
C. Wanner Germany 11 188 1.0× 100 0.7× 89 0.8× 70 0.8× 59 1.1× 24 376
Takahiro Yamaji Japan 13 139 0.8× 81 0.6× 131 1.2× 74 0.8× 45 0.8× 28 520
Xiaole Su China 13 300 1.7× 87 0.6× 72 0.7× 144 1.6× 53 0.9× 30 578
Jenny Wei United States 3 140 0.8× 146 1.1× 64 0.6× 31 0.3× 44 0.8× 7 366
Jing‐Wei Gao China 13 77 0.4× 121 0.9× 139 1.3× 102 1.1× 31 0.6× 38 452
Rosalia Arsena Italy 12 173 1.0× 193 1.4× 57 0.5× 56 0.6× 49 0.9× 17 504
Jacentha Buggs United States 14 115 0.6× 66 0.5× 87 0.8× 132 1.5× 46 0.8× 42 388
Calogero Geraci Italy 10 137 0.8× 160 1.2× 39 0.4× 54 0.6× 79 1.4× 11 355
Raffaella Riccobene Italy 10 221 1.2× 253 1.8× 64 0.6× 44 0.5× 66 1.2× 13 528

Countries citing papers authored by Ziad Massy

Since Specialization
Citations

This map shows the geographic impact of Ziad Massy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziad Massy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziad Massy more than expected).

Fields of papers citing papers by Ziad Massy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziad Massy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziad Massy. The network helps show where Ziad Massy may publish in the future.

Co-authorship network of co-authors of Ziad Massy

This figure shows the co-authorship network connecting the top 25 collaborators of Ziad Massy. A scholar is included among the top collaborators of Ziad Massy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziad Massy. Ziad Massy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Liabeuf, Sophie, et al.. (2025). Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate. Fundamental and Clinical Pharmacology. 39(4). 1–10.
2.
Zoccali, Carmine, Marc Vervloet, Pieter Evenepoel, et al.. (2025). Autonomic Nervous System Dysregulation and Bone Health in Patients with CKD. Clinical Journal of the American Society of Nephrology. 20(7). 1000–1002. 1 indexed citations
3.
Larabi, Islam Amine, Solène M. Laville, Maurice Laville, et al.. (2025). Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD. Kidney International Reports. 10(7). 2165–2177.
4.
Zoccali, Carmine, Marc Vervloet, Pieter Evenepoel, et al.. (2025). The autonomic nervous system and bone health in chronic kidney disease. European Journal of Clinical Investigation. 55(5). e70007–e70007.
6.
Perreault, Sylvie, et al.. (2023). Effectiveness and safety of apixaban and rivaroxaban vs warfarin in patients with atrial fibrillation and chronic kidney disease. World Journal of Nephrology. 12(5). 132–146. 2 indexed citations
7.
Liabeuf, Sophie, et al.. (2022). Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?. Toxins. 14(4). 280–280. 36 indexed citations
8.
Tabibzadeh, Nahid, Romuald Mentaverri, Maïté Daroux, et al.. (2018). Differential Determinants of Tubular Phosphate Reabsorption: Insights on Renal Excretion of Phosphates in Kidney Disease. American Journal of Nephrology. 47(5). 300–303. 4 indexed citations
9.
Ferro, Charles J., Patrick B. Mark, Mehmet Kanbay, et al.. (2018). Lipid management in patients with chronic kidney disease. Nature Reviews Nephrology. 14(12). 727–749. 172 indexed citations
10.
Vanholder, R., Denis Fouque, Gunnar H. Heine, et al.. (2016). Clinical management of the uraemic syndrome in chronic kidney disease. The Lancet Diabetes & Endocrinology. 4(4). 360–373. 73 indexed citations
11.
Rossignol, Patrick, Ziad Massy, Michel Azizi, et al.. (2015). The double challenge of resistant hypertension and chronic kidney disease. The Lancet. 386(10003). 1588–1598. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026